Envoya
Envoya is a pioneering biomedical technology company focused on revolutionizing gene therapy through the development of polymer-based nanoparticles for targeted delivery. Leveraging AI-driven design and advanced polymer science, Envoya creates precise delivery systems that maximize target specificity, minimize off-target toxicity, and reduce development time and cost. Their Envoyer Nanoparticles are designed to deliver various genetic materials, including siRNA, mRNA, DNA, and CRISPR components, with high efficiency. Envoya offers flexible partnership models, tailoring solutions to specific therapeutic goals and R&D pipelines, ultimately aiming to accelerate breakthroughs and improve patient lives by addressing gene therapy's delivery barriers.
Envoya
Envoya is a pioneering biomedical technology company focused on revolutionizing gene therapy through the development of polymer-based nanoparticles for targeted delivery. Leveraging AI-driven design and advanced polymer science, Envoya creates precise delivery systems that maximize target specificity, minimize off-target toxicity, and reduce development time and cost. Their Envoyer Nanoparticles are designed to deliver various genetic materials, including siRNA, mRNA, DNA, and CRISPR components, with high efficiency. Envoya offers flexible partnership models, tailoring solutions to specific therapeutic goals and R&D pipelines, ultimately aiming to accelerate breakthroughs and improve patient lives by addressing gene therapy's delivery barriers.